{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:09:38Z","timestamp":1779178178397,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"DOI":"10.7759\/cureus.109165","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:54:52Z","timestamp":1779177292000},"source":"Crossref","is-referenced-by-count":0,"title":["ABO Discrepancy in Multiple Myeloma Initially Suspected as a Complication of COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Akanksha","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvi","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gogoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Diwaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani A","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020, 217:108480. 10.1016\/j.clim.2020.108480","journal-title":"Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157138","article-title":"SARS-CoV-2 vaccinations do not lead to progression of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study","volume":"140","author":"Palmason R","year":"2022","unstructured":"Palmason R, Eythorsson E, R\u00f6gnvaldsson S, et al.. SARS-CoV-2 vaccinations do not lead to progression of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study. Blood. 2022, 140:261-3. 10.1182\/blood-2022-157138","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100785","article-title":"The impact of ABO blood group on COVID-19 infection risk and mortality: a systematic review and meta-analysis","volume":"48","author":"Liu N","year":"2021","unstructured":"Liu N, Zhang T, Ma L, et al.. The impact of ABO blood group on COVID-19 infection risk and mortality: a systematic review and meta-analysis. Blood Rev. 2021, 48:100785. 10.1016\/j.blre.2020.100785","journal-title":"Blood Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/gjtm.gjtm_95_22","article-title":"Transitory absence of ABO antibodies during severe acute respiratory syndrome coronavirus 2 infection","volume":"8","author":"Das S","year":"2023","unstructured":"Das S, Karaskar M, Dabhekar SB, et al.. Transitory absence of ABO antibodies during severe acute respiratory syndrome coronavirus 2 infection. Glob J Transfus Med. 2023, 8:62-4. 10.4103\/gjtm.gjtm_95_22","journal-title":"Glob J Transfus Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67096","article-title":"ABO discrepancy in a patient with plasma cell myeloma","volume":"16","author":"Adzahar S","year":"2024","unstructured":"Adzahar S, Daud A, Razak SM, et al.. ABO discrepancy in a patient with plasma cell myeloma. Cureus. 2024, 16:e67096. 10.7759\/cureus.67096","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep17040031","article-title":"Uncommon entities, uncommon challenges: a review of rare plasma cell disorders","volume":"17","author":"Hanbali A","year":"2025","unstructured":"Hanbali A, Alamer A, Alhayli S. Uncommon entities, uncommon challenges: a review of rare plasma cell disorders. Hematol Rep. 2025, 17:31. 10.3390\/hematolrep17040031","journal-title":"Hematol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"132","author":"Rodr\u00edguez Y","year":"2022","unstructured":"Rodr\u00edguez Y, Rojas M, Beltr\u00e1n S, et al.. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun. 2022, 132:102898. 10.1016\/j.jaut.2022.102898","journal-title":"J Autoimmun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:1086-107. 10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2023.08.004","article-title":"Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases","volume":"18","author":"Yaamika H","year":"2023","unstructured":"Yaamika H, Muralidas D, Elumalai K. Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases. J Taibah Univ Med Sci. 2023, 18:1646-61. 10.1016\/j.jtumed.2023.08.004","journal-title":"J Taibah Univ Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.34172\/bi.2023.27494","article-title":"SARS-CoV-2 vaccine-triggered autoimmunity: molecular mimicry and\/or bystander activation of the immune system","volume":"13","author":"Safary A","year":"2023","unstructured":"Safary A, Akbarzadeh-Khiavi M, Barar J, Omidi Y. SARS-CoV-2 vaccine-triggered autoimmunity: molecular mimicry and\/or bystander activation of the immune system. Bioimpacts. 2023, 13:269-73. 10.34172\/bi.2023.27494","journal-title":"Bioimpacts"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060961","article-title":"COVID-19 vaccines and autoimmune hematologic disorders","volume":"10","author":"Mingot-Castellano ME","year":"2022","unstructured":"Mingot-Castellano ME, Butta N, Canaro M, et al.. COVID-19 vaccines and autoimmune hematologic disorders. Vaccines (Basel). 2022, 10:961. 10.3390\/vaccines10060961","journal-title":"Vaccines (Basel)"},{"key":"ref12","article-title":"ABO typing discrepancies","author":"Fathima S","year":"2026","unstructured":"Fathima S, Killeen RB. ABO typing discrepancies. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493896-abo-discrepancy-in-multiple-myeloma-initially-suspected-as-a-complication-of-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:54:53Z","timestamp":1779177293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493896-abo-discrepancy-in-multiple-myeloma-initially-suspected-as-a-complication-of-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.109165","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}